Newsletter Signup
Stay up to date on all the latest news from Boston.com
Reports of a new viral infection may prompt fear after the challenges the world has faced through the COVID-19 pandemic, but a Boston infectious disease doctor is stressing the situation is not the same.
“Let me start by saying that any monkeypox is a very different virus than COVID-19,” Dr. Nahid Bhadelia, director of Boston University’s Center for Emerging Infectious Diseases Policy and Research, said on MSNBC Sunday.
Monkeypox — which presents with symptoms including a fever, headache, and muscle aches and can progress to create a rash, according to the Centers for Disease Control and Prevention — is in the same family as smallpox, Bhadelia said.
The good news is the virus is not as deadly as smallpox, she said.
“The interesting thing here is that because monkeypox and smallpox were so closely related, for a very long time when we were vaccinating against smallpox, it was cross protection against monkeypox,” Bhadelia said. “The theory has been since we eradicated smallpox, and we’re not vaccinating, we created a generation of humans on the face of this earth who are not immune to monkeypox now.”
The World Health Organization released a report on Saturday saying there have been 92 laboratory confirmed cases and 28 suspected cases in areas that are not endemic for the virus.
“The concern here is that could this have been something that’s a change in the virus?” Bhadelia said. “Thankfully, that doesn’t seem to be the case currently, it still remains a hard to transmit virus compared to other things like COVID.”
The first confirmed case of the virus in the United States was in a man in Massachusetts who had recently traveled to Canada. The Massachusetts Department of Public Health has said the case poses no risk to the general public. A handful of other cases are starting to show up in the United States, including a potential case being reported in Florida and a confirmed case in New York.
Bhadelia said the almost 100 cases could also stem from an unlucky introduction of a case from travel into a vulnerable population.
“Could it be that potentially there are a lot more cases and now that we’ve raised alarm for it, physicians are looking out for it a lot more,” Bhadelia said. “The kind of rash that this virus causes, for others who are looking at it, might look like chickenpox or herpes, so [it] could be missed.”
Bhadelia called monkeypox a “matter of concern,” but she emphasized that with good epidemiology and contact tracing, she doesn’t expect the case numbers to rise too much.
“The good news I want people to know is that we have an effective vaccine against monkeypox; it’s part of the national stockpile,” Bhadelia said. “We have antiviral medications that may work and we don’t expect these clusters to get bigger.”
As if surging Covid cases wasn’t enough, health officials are monitoring the rise of a new rare virus: #monkeypox. @BhadeliaMD says the good news is “we have an effective vaccine against monkeypox..we have antiviral medications..but of course, it’s a matter of concern” #Velshi pic.twitter.com/W8b5HM0Ky9
— Velshi on MSNBC (@VelshiMSNBC) May 22, 2022
Stay up to date on all the latest news from Boston.com
Stay up to date with everything Boston. Receive the latest news and breaking updates, straight from our newsroom to your inbox.
Conversation
This discussion has ended. Please join elsewhere on Boston.com